Molina Healthcare (MOH) EBITDA (2010 - 2026)

Molina Healthcare has disclosed EBITDA across 17 years of filings, most recently posting $83.0 million for Q1 2026.

• EBITDA for Q1 2026 came in at $83.0 million, down 80.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 22.93% YoY), and the FY2025 annual result was $788.0 million, down 54.27% from the prior year.
• EBITDA came in at $83.0 million for Q1 2026 at Molina Healthcare, down from $459.0 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $459.0 million in Q4 2025 to a low of $11.0 million in Q1 2022.
• The 5-year median for EBITDA is $338.5 million (2022), against an average of $265.2 million.
• Across the five-year window, EBITDA slumped 96.72% in 2022 and surged 4036.36% in 2023, its largest moves.
• Molina Healthcare's EBITDA stood at $49.0 million in 2022, then soared by 544.9% to $316.0 million in 2023, then increased by 20.25% to $380.0 million in 2024, then rose by 20.79% to $459.0 million in 2025, then plunged by 81.92% to $83.0 million in 2026.
• The last three EBITDA figures came in at $83.0 million (Q1 2026), $459.0 million (Q4 2025), and $137.0 million (Q3 2025), per Business Quant data.